Bradley Foster & Sargent’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Buy
230,782
+8,387
+4% +$509K 0.24% 93
2026
Q1
$10.9M Sell
222,395
-70,196
-24% -$3.28M 0.17% 111
2025
Q4
$10.5M Buy
292,591
+4,114
+1% +$167K 0.15% 112
2025
Q3
$13.1M Buy
288,477
+20,064
+7% +$812K 0.19% 99
2025
Q2
$8.51M Buy
+268,413
New +$7.69M 0.13% 123
2020
Q1
$492K Buy
+11,645
New +$583K 0.02% 233
2019
Q2
Sell
-20,250
Closed -$1.03M 345
2019
Q1
$1.03M Buy
20,250
+7,040
+53% +$337K 0.04% 207
2018
Q4
$511K Buy
+13,210
New +$573K 0.02% 252
2015
Q3
Sell
-24,310
Closed -$585K 333
2015
Q2
$585K Buy
24,310
+5,310
+28% +$130K 0.03% 240
2015
Q1
$471K Buy
+19,000
New +$404K 0.02% 265

Other funds holding CGNX

Bradley Foster & Sargent's CGNX Position: Q2 2026 in Review

Bradley Foster & Sargent increased its Cognex (CGNX) stake by 3.8% in Q2 2026, buying an estimated $509K and bringing the position to 230,782 shares worth $16.7M. The position accounts for 0.24% of the portfolio, ranked #93.

Bradley Foster & Sargent first reported a position in CGNX in Q1 2015 and has held it in 10 quarters since. 649 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • Bradley Foster & Sargent held 230,782 shares of Cognex worth $16.7M as of Q2 2026.
  • Bradley Foster & Sargent bought 8,387 Cognex shares in Q2 2026, an estimated $509K.
  • Cognex made up 0.24% of Bradley Foster & Sargent's portfolio in Q2 2026, its #93 holding.
  • Bradley Foster & Sargent first reported a position in Cognex in Q1 2015 and has held it in 10 quarters since.
  • 649 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.